Home
Conditions
Neoplasms, Plasma Cell

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

512 public trials 52 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Completed

Dendritic Cell Vaccine in Treating Patients With Indolent B-Cell Lymphoma or Multiple Myeloma

NCT00937183

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology - Warsaw Warsaw, Poland

View Trial Details

Completed

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

NCT00874211

Conditions: Blood Protein Disorders, Breast Cancer, Breast Diseases, +45 more
Locations: Regional Medical Center Anniston, Alabama, United States

Providence Cancer Center at Providence Hospital Mobile, Alabama, United States

Providence Cancer Center Anchorage, Alaska, United States

Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital Fairbanks, Alaska, United States

View all 453 locations

View Trial Details

Completed

Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma

NCT00004088

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Banner Good Samaritan Medical Center Phoenix, Arizona, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

View Trial Details

Completed

Nelfinavir as Bortezomib-sensitizing Drug in Patients With Proteasome Inhibitor-nonresponsive Myeloma

NCT02188537

Conditions: Myeloma, Neoplasms, Neoplasms by Histologic Type, +1 more
Locations: Kantonsspital Aarau Aarau, Switzerland

Kantonsspital Baden Baden, Switzerland

Universitaetsspital-Basel Basel, Switzerland

Istituto Oncologico Svizzera Italiana IOSI Bellinzona, Switzerland

View Trial Details

Completed

Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer

NCT01164709

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Congenital Abnormalities, +42 more
Locations: Inselspital Bern Bern, Switzerland

Kantonsspital Graubuenden Chur, Switzerland

Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland

Kantonsspital - St. Gallen Sankt Gallen, Switzerland

View Trial Details

Completed

Novel Support Options in Autologous Stem Cell Transplant for Multiple Myeloma

NCT02274519

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

View Trial Details

Completed

Targeted Radiotherapy in HSCT for Poor Risk Haematological Malignancy

NCT01521611

Conditions: Acute Leukaemia, Chronic Leukaemia, Hemic and Lymphatic Diseases, +9 more
Locations: Southampton University Hospitals NHS Trust Southampton, Hampshire, United Kingdom

Royal Free Hospital and University College London London, United Kingdom

View Trial Details

Completed

Adoptive Cellular Immunotherapy Following Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma

NCT00439465

Conditions: Myeloma, Neoplasms, Neoplasms by Histologic Type, +2 more
Locations: Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States

View Trial Details

Completed

Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) Patients

NCT01440582

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

First Line Treatment Trial in Multiple Myeloma, Finnish Myeloma Group- Multiple Myeloma 02

NCT01790737

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Kuopio University Hospital Kuopio, Northern Savonia, Finland

Tampere University Hospital Tampere, Pirkanmaa, Finland

Kanta-Häme Central Hospital Hämeenlinna, Finland

Helsinki University Hospital Helsinki, Finland

View Trial Details

Neoplasms, Plasma Cell

Neoplasms, Plasma Cell trial results

Related conditions